berberine and 1-methyl-3-isobutylxanthine

berberine has been researched along with 1-methyl-3-isobutylxanthine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gong, Z; Huang, C; Li, Z; Qin, Y; Sheng, X; Zhang, W; Zhang, Y1
Chen, M; Li, F; Ning, G; Wang, N; Wang, X; Wu, L; Yang, Y; Yuan, G; Zhang, R; Zhou, L1

Other Studies

2 other study(ies) available for berberine and 1-methyl-3-isobutylxanthine

ArticleYear
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway.
    Biochemical and biophysical research communications, 2006, Sep-22, Volume: 348, Issue:2

    Topics: 1-Methyl-3-isobutylxanthine; 3T3-L1 Cells; Adipocytes; Animals; Berberine; CCAAT-Enhancer-Binding Protein-alpha; CCAAT-Enhancer-Binding Protein-beta; Cell Differentiation; Cell Proliferation; Dexamethasone; Gene Expression Profiling; Insulin; Mice; PPAR alpha; PPAR gamma; Transcription Factors; Transcriptional Activation

2006
Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes.
    Biochimica et biophysica acta, 2011, Volume: 1812, Issue:4

    Topics: 1-Methyl-3-isobutylxanthine; 3T3-L1 Cells; Adipocytes; AMP-Activated Protein Kinases; Animals; Berberine; Carrier Proteins; Catecholamines; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Hypoglycemic Agents; Lipolysis; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Perilipin-1; Phosphodiesterase Inhibitors; Phosphoproteins; Sterol Esterase

2011